Tower Research Capital (TRC)’s CARGO Therapeutics CRGX Stock Holding History

Tower Research Capital (TRC)’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,879	Closed	-$24.2K	–	5273
2025 Q2	$24.2K	Sell	5,879 -1,234	-17%	-$5.29K	﹤0.01%	3570
2025 Q1	$28.9K	Buy	7,113 +1,313	+23%	+$8.79K	﹤0.01%	2645
2024 Q4	$83.6K	Buy	5,800 +4,929	+566%	+$89.5K	﹤0.01%	2254
2024 Q3	$16.1K	Sell	871 -3,125	-78%	-$55.9K	﹤0.01%	3384
2024 Q2	$65.6K	Buy	3,996 +2,082	+109%	+$39.6K	﹤0.01%	2884
2024 Q1	$42.7K	Buy	+1,914	New	+$45.5K	﹤0.01%	2393

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Tower Research Capital (TRC)'s CRGX Position: Q3 2025 in Review

Tower Research Capital (TRC) sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 5,879 shares — an estimated $24.2K sold.

Tower Research Capital (TRC) first reported a position in CRGX in Q1 2024 and held it in 6 quarters. The position peaked at $83.6K in Q4 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

Tower Research Capital (TRC) reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
Tower Research Capital (TRC) sold 5,879 CARGO Therapeutics shares in Q3 2025, an estimated $24.2K.
Tower Research Capital (TRC) first reported a position in CARGO Therapeutics in Q1 2024 and held it in 6 quarters.
Tower Research Capital (TRC)'s CARGO Therapeutics position peaked at $83.6K in Q4 2024.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.